Stay updated on GSK2857916 Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.

Latest updates to the GSK2857916 Dose Escalation Clinical Trial page
- Check2 days agoChange DetectedA new revision tag, v3.5.4, was added to the page, and several related topics entries (e.g., Multiple myeloma and MedlinePlus Genetics) were removed from the related topics/MeSH area, indicating metadata cleanup rather than a change to study information.SummaryDifference0.2%

- Check9 days agoChange DetectedAdded related-topic links for Multiple myeloma and MedlinePlus Genetics under the related topics section to connect the study page with disease-specific and genetic resources.SummaryDifference0.1%

- Check16 days agoChange DetectedThe page's footer navigation references to related topics and MedlinePlus Genetics are removed. This reduces ancillary navigation text without altering the main study information.SummaryDifference0.1%

- Check24 days agoChange DetectedThe page footer was updated to reflect a new ClinicalTrials.gov software/content revision label (v3.5.3 instead of v3.5.2). This represents a site/version update rather than a change to the study record content.SummaryDifference0.0%

- Check31 days agoChange DetectedRevision updated to v3.5.2, replacing the previous v3.5.0; this appears to be a metadata change with no impact on study details or user experience.SummaryDifference0.0%

- Check60 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0 and related topics 'Multiple Myeloma' and 'MedlinePlus Genetics' were added.SummaryDifference0.2%

Stay in the know with updates to GSK2857916 Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.